These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 6388344)

  • 1. Chemotactic activity generated in human serum from the fifth component of complement by hydrogen peroxide.
    Shingu M; Nobunaga M
    Am J Pathol; 1984 Nov; 117(2):201-6. PubMed ID: 6388344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Group B streptococci inhibit the chemotactic activity of the fifth component of complement.
    Hill HR; Bohnsack JF; Morris EZ; Augustine NH; Parker CJ; Cleary PP; Wu JT
    J Immunol; 1988 Nov; 141(10):3551-6. PubMed ID: 3053900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of a neutrophil chemotactic agent by spermatozoa: role of complement and regulation by seminal plasma factors.
    Clark RA; Klebanoff SJ
    J Immunol; 1976 Oct; 117(4):1378-86. PubMed ID: 977954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotactic factor inactivation by stimulated human neutrophils mediated by myeloperoxidase-catalyzed methionine oxidation.
    Clark RA; Szot S
    J Immunol; 1982 Apr; 128(4):1507-13. PubMed ID: 6278020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of chemotactic factor inactivator in modulating alveolar macrophage-derived neutrophil chemotactic activity.
    Robbins RA; Justice JM; Rasmussen JK; Russ WD; Thomas KR; Rennard SI
    J Lab Clin Med; 1987 Feb; 109(2):164-70. PubMed ID: 3805869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of a fibroblast chemotactic factor in serum by activation of complement.
    Postlethwaite AE; Snyderman R; Kang AH
    J Clin Invest; 1979 Nov; 64(5):1379-85. PubMed ID: 91624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific inhibitor of complement (C5)-derived chemotactic activity in systemic lupus erythematosus related antigenically to the Bb fragment of human factor B.
    Perez HD; Hooper C; Volanakis J; Ueda A
    J Immunol; 1987 Jul; 139(2):484-9. PubMed ID: 3648093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigenic identification of chemotactic factor inactivator in normal human serum and bronchoalveolar lavage fluid.
    Robbins RA; Rasmussen JK; Clayton ME; Gossman GL; Kendall TJ; Rennard SI
    J Lab Clin Med; 1987 Sep; 110(3):292-9. PubMed ID: 3611952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of chemotactic factor inactivation in neutrophil chemotaxis.
    Tannous R; Cavender-Zylich N; Ginsberg BH
    J Lab Clin Med; 1981 Aug; 98(2):238-50. PubMed ID: 7252332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of biologically active, complement-(C5) derived peptides by cathepsin H.
    Perez HD; Ohtani O; Banda D; Ong R; Fukuyama K; Goldstein IM
    J Immunol; 1983 Jul; 131(1):397-402. PubMed ID: 6408181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of a complement-derived chemotactic factor for tumor cells in experimentally induced peritoneal exudates and its effect on the local metastasis of circulating tumor cells.
    Orr FW; Mokashi S; Delikatny J
    Am J Pathol; 1982 Jul; 108(1):112-8. PubMed ID: 7091299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydrogen peroxide-induced chemotaxis of mouse peritoneal neutrophils.
    Klyubin IV; Kirpichnikova KM; Gamaley IA
    Eur J Cell Biol; 1996 Aug; 70(4):347-51. PubMed ID: 8864663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presence of chemotactic peptides other than C5a anaphylatoxin in scales of psoriasis and sterile pustular dermatoses.
    Takematsu H; Terui T; Ohkohchi K; Tagami H; Suzuki R; Kumagai K
    Acta Derm Venereol; 1986; 66(2):93-7. PubMed ID: 2424251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partial characterization of a bone-derived chemotactic factor for tumor cells.
    Orr FW; Varani J; Gondek MD; Ward PA; Mundy GR
    Am J Pathol; 1980 Apr; 99(1):43-52. PubMed ID: 7361862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of a complement-derived chemotactic factor for tumor cells in human inflammatory and neoplastic effusions.
    Orr FW; Delikatny EJ; Mokashi S; Krepart GV; Stiver HG
    Am J Pathol; 1983 Jan; 110(1):41-7. PubMed ID: 6185003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of complement in normal serum by hydrogen peroxide and hydrogen peroxide-related oxygen radicals produced by activated neutrophils.
    Shingu M; Nonaka S; Nishimukai H; Nobunaga M; Kitamura H; Tomo-Oka K
    Clin Exp Immunol; 1992 Oct; 90(1):72-8. PubMed ID: 1327592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attachment of human C5a des Arg to its cochemotaxin is required for maximum expression of chemotactic activity.
    Perez HD; Chenoweth DE; Goldstein IM
    J Clin Invest; 1986 Dec; 78(6):1589-95. PubMed ID: 3782473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of the chemotactic activity of human C5a des Arg by an anionic polypeptide ("cochemotaxin") in normal serum and plasma.
    Perez HD; Goldstein IM; Webster RO; Henson PM
    J Immunol; 1981 Feb; 126(2):800-4. PubMed ID: 7451994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of the fifth and sixth components of the human complement system: C6-dependent cleavage of C5 in acid and the formation of a bimolecular lytic complex, C5b,6a.
    Hammer CH; Hänsch G; Gresham HD; Shin ML
    J Immunol; 1983 Aug; 131(2):892-8. PubMed ID: 6863934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of chemotactic activity in normal guinea pig serum by treatment with acid.
    Kownatzki E; Uhrich S
    Immunobiology; 1983 Dec; 165(5):393-402. PubMed ID: 6662553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.